Synthesis and biological evaluation of indole-based UC-112 analogs as potent and selective survivin inhibitors.

[1]  R. Kanwar,et al.  Survivin Modulators: An Updated Patent Review (2011-2015). , 2016, Recent patents on anti-cancer drug discovery.

[2]  Jing Qi,et al.  Effective Targeting of the Survivin Dimerization Interface with Small-Molecule Inhibitors. , 2016, Cancer research.

[3]  Duane D. Miller,et al.  Structural Optimization of Indole Derivatives Acting at Colchicine Binding Site as Potential Anticancer Agents. , 2015, ACS medicinal chemistry letters.

[4]  Duane D. Miller,et al.  Design, Synthesis and Structure-Activity Relationship Studies of Novel Survivin Inhibitors with Potent Anti-Proliferative Properties , 2015, PloS one.

[5]  Wei Li,et al.  Recent Advances on Small-Molecule Survivin Inhibitors , 2015, Current medicinal chemistry.

[6]  Jin Wang,et al.  Discovery of Novel Second Mitochondria-Derived Activator of Caspase Mimetics as Selective Inhibitor of Apoptosis Protein Inhibitors , 2014, The Journal of Pharmacology and Experimental Therapeutics.

[7]  G. Schneider,et al.  Survivin and YM155: how faithful is the liaison? , 2014, Biochimica et biophysica acta.

[8]  Jing Wang,et al.  Arctigenin Enhances Chemosensitivity to Cisplatin in Human Nonsmall Lung Cancer H460 Cells through Downregulation of Survivin Expression , 2014, Journal of biochemical and molecular toxicology.

[9]  Duane D. Miller,et al.  Synergistic Combination of Novel Tubulin Inhibitor ABI-274 and Vemurafenib Overcomes Vemurafenib Acquired Resistance in BRAFV600E Melanoma , 2013, Molecular Cancer Therapeutics.

[10]  M. Coumar,et al.  Treat cancers by targeting survivin: just a dream or future reality? , 2013, Cancer treatment reviews.

[11]  Fengzhi Li,et al.  A Novel Small Molecule FL118 That Selectively Inhibits Survivin, Mcl-1, XIAP and cIAP2 in a p53-Independent Manner, Shows Superior Antitumor Activity , 2012, PloS one.

[12]  Hongli Liu,et al.  Notch-1 signaling facilitates survivin expression in human non-small cell lung cancer cells , 2011, Cancer biology & therapy.

[13]  M. P. Holloway,et al.  EGF regulates survivin stability through the Raf-1/ERK pathway in insulin-secreting pancreatic β-cells , 2010, BMC Molecular Biology.

[14]  N. Mahindroo,et al.  Amide conjugates of ketoprofen and indole as inhibitors of Gli1-mediated transcription in the Hedgehog pathway. , 2010, Bioorganic & medicinal chemistry.

[15]  M. Duffy,et al.  Survivin: a new target for anti-cancer therapy. , 2009, Cancer treatment reviews.

[16]  H. Hsieh,et al.  Survivin counteracts the therapeutic effect of microtubule de-stabilizers by stabilizing tubulin polymers , 2009, Molecular Cancer.

[17]  M. Ranson,et al.  First human dose study evaluating safety and pharmacokinetics of LY2181308, an antisense oligonucleotide designed to inhibit survivin , 2008 .

[18]  T. Fojo,et al.  Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1((R)). , 2008, Biochemical pharmacology.

[19]  D. Altieri.  Survivin, cancer networks and pathway-directed drug discovery , 2008, Nature Reviews Cancer.

[20]  S. Hatakeyama,et al.  YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts. , 2007, Cancer research.

[21]  N. Zaffaroni,et al.  Targeting survivin in cancer therapy: fulfilled promises and open questions. , 2007, Carcinogenesis.

[22]  M. Duffy,et al.  Survivin: a promising tumor biomarker. , 2007, Cancer letters.

[23]  N. London,et al.  Induction of melanoma cell apoptosis and inhibition of tumor growth using a cell-permeable Survivin antagonist , 2006, Oncogene.

[24]  Chuang Lu,et al.  Comparison of Intrinsic Clearance in Liver Microsomes and Hepatocytes from Rats and Humans: Evaluation of Free Fraction and Uptake in Hepatocytes , 2006, Drug Metabolism and Disposition.

[25]  L. Di,et al.  High throughput microsomal stability assay for insoluble compounds. , 2006, International journal of pharmaceutics.

[26]  M. A. Hardwicke,et al.  Regulation of survivin by ErbB2 signaling: therapeutic implications for ErbB2-overexpressing breast cancers. , 2006, Cancer research.

[27]  A. Chakravarti,et al.  Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms , 2004, Oncogene.

[28]  Ru-chih C. Huang,et al.  Tetra-O-methyl nordihydroguaiaretic acid induces growth arrest and cellular apoptosis by inhibiting Cdc2 and survivin expression. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[29]  C. Nguyên,et al.  A small molecule inhibitor of β-catenin/cyclic AMP response element-binding protein transcription , 2004 .

[30]  Hong Ma,et al.  A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected]. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Tim Morris,et al.  Physiological Parameters in Laboratory Animals and Humans , 1993, Pharmaceutical Research.

[32]  P. Shastry,et al.  Upregulation of survivin in G2/M cells and inhibition of caspase 9 activity enhances resistance in staurosporine-induced apoptosis. , 2004, Neoplasia.

[33]  Y. Pommier,et al.  Suppression of survivin phosphorylation on Thr34 by flavopiridol enhances tumor cell apoptosis. , 2003, Cancer research.

[34]  Jiandong Chen,et al.  Transcriptional Repression of the Anti-apoptoticsurvivin Gene by Wild Type p53* , 2002, The Journal of Biological Chemistry.

[35]  Hui Zhang,et al.  Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Robert L. Margolis,et al.  Crystal Structure of Human Survivin Reveals a Bow Tie?Shaped Dimer with Two Unusual ?-Helical Extensions , 2000 .

[37]  James B. Mitchell,et al.  Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. , 1987, Cancer research.

[38]  I. Pastan,et al.  Isolation and genetic characterization of human KB cell lines resistant to multiple drugs , 1985, Somatic cell and molecular genetics.